Markets

Crescita Therapeutics Posts Wider Net Loss In Q1

May 11, 2026 — 08:03 am EDT

Written by RTTNews.com for RTTNews->

(RTTNews) - Crescita Therapeutics Inc. (CRRTF.PK, CTX.TO), Monday announced its first-quarter financial results, reporting a net loss of C$1.160 million, or C$0.06 a share, compared to C$0.932 million, or C$0.05 a share, last year.

Operating loss amounted to C$1.2 million compared to C$1.1 million in the earlier year.

Revenues increased to C$5.6 million from C$3.5 million in the prior year.

Crescita's stock closed trading at $0.5731 on the OTC Markets on Friday.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.